筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer):世界の治験レビュー(2015年上半期版)

【英語タイトル】Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2600CTIDB)・商品コード:GDHC2600CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年2月27日
・ページ数:69
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥802,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer)
  - 当レポートの概要
・筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015″ provides data on the Muscle Invasive Bladder Cancer (MIBC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Invasive Bladder Cancer (MIBC). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Muscle Invasive Bladder Cancer (MIBC) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Muscle Invasive Bladder Cancer (MIBC) 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Celldex Therapeutics, Inc. 31
Clinical Trial Overview of Celldex Therapeutics, Inc. 31
Astellas Pharma Inc. 32
Clinical Trial Overview of Astellas Pharma Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
Memorial Sloan Kettering Cancer Center 33
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33
Fox Chase Cancer Center 34
Clinical Trial Overview of Fox Chase Cancer Center 34
Trans Tasman Radiation Oncology Group 35
Clinical Trial Overview of Trans Tasman Radiation Oncology Group 35
Brown University 36
Clinical Trial Overview of Brown University 36
Centre Val d’Aurelle – Paul Lamarque 37
Clinical Trial Overview of Centre Val d’Aurelle – Paul Lamarque 37
Nara Medical University 38
Clinical Trial Overview of Nara Medical University 38
Hiroshima University Hospital 39
Clinical Trial Overview of Hiroshima University Hospital 39
Hirosaki University 40
Clinical Trial Overview of Hirosaki University 40
Sun Yat-sen University 41
Clinical Trial Overview of Sun Yat-sen University 41
Tata Memorial Hospital 42
Clinical Trial Overview of Tata Memorial Hospital 42
Five Key Clinical Profiles 43
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69

List of Tables
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015* 31
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 32
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 33
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 34
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Trans Tasman Radiation Oncology Group, 2015* 35
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2015* 36
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2015* 37
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nara Medical University, 2015* 38
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* 39
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hirosaki University, 2015* 40
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 41
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tata Memorial Hospital, 2015* 42

List of Figures
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 67

【レポートのキーワード】

筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer)、治験、臨床試験、治験、治療薬

★調査レポート[筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer):世界の治験レビュー(2015年上半期版)] (コード:GDHC2600CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[筋層浸潤膀胱癌(MIBC)(Muscle Invasive Bladder Cancer):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆